18 research outputs found
Antagonism of Sorafenib and Regorafenib actions by platelet factors in hepatocellular carcinoma cell lines
Full text linkProteomic analysis identifies argininosuccinate synthase 1 as a useful biomarker for hepatocellular adenoma classification and patient management
No full textInternational audienc
Combining laser capture microdissection and proteomics reveals an active translation machinery controlling invadosome formation
No full text10.1038/s41467-018-04461-9Nature Communications91446
Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study
No full textInactivation of hypoxia-induced YAP by statins overcomes hypoxic resistance tosorafenib in hepatocellular carcinoma cells
No full textSecond line systemic therapy options for advanced hepatocellular carcinoma; a systematic review
No full text
miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR
No full textPatient-derived multicellular tumor spheroids towards optimized treatment for patients with hepatocellular carcinoma
No full text
